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Abstract 
Chalcones are diphenyl α-β-unsaturated compounds that are present in a wide 
variety of plants. Naturally occurring chalcones as well as synthetic chalcones have 
demonstrated an assortment of biological activity, including anti-inflammatory, anti-
viral and antimicrobial activity. The need for new antimicrobially active agents is 
becoming more imperative as antimicrobial resistance continues to present a large 
threat. In this project, a series of chalcones were synthesised via a Claisen-Schmidt 
condensation reaction. The compounds were analysed using NMR spectroscopy 
and Gas-Chromatography Mass Spectrometry. An attempt was made to convert 
four of the chalcones to thiochalcones using Lawesson’s Reagent. The compounds 
were tested against E. coli, P. aeruginosa and S. epidermidis. None of the 
synthesised chalcones displayed any antimicrobial activity but the thiochalcones 
showed activity against all bacterial strains. Upon further analysis, the thiochalcones 
appeared to have decomposed in situ, with the major product being the oxa-thio-
phosphorane compound. This compound could have been the cause behind the 
activity seen in compound 11 against S. epidermidis and compound 14 against all 
bacterial strains studied. Compound 11 produced a zone of inhibition of 10mm 
against S. epidermidis whilst compound 14 produced zones of inhibition against S. 
epidermidis, P. aeruginosa and E. coli of 16mm, 10.3mm and 15.3mm respectively. 
The MICs and MBCs of the compounds were not greater than Ciprofloxacin, the 
antibiotic used in this project as the positive control, as shown by the results. 
   1 
1. Introduction 
Antimicrobial resistance is defined as the ability of a microorganism such as bacteria 
to grow in the presence of antimicrobial agents designed to hinder or halt their 
growth and reproduction. This resistance usually develops as a result of continuous 
exposure to said agents leading to selective pressure: either the population dies 
from contact or a mutation arises in a population, allowing for resistance (Amábile-
Cuevas, 2010). It should be noted that some microbes that have never come into 
contact with antibiotics can also be resistant depending on the extremity of the 
environments in which they are found (D’Costa et al, 2011). This has become more 
of a problem in recent times due to the rise of not only more antibiotic-resistant 
bacteria but also multi-drug resistance. The efficacy of available antibiotics is 
becoming increasingly less effective. Dr Margaret Chan, former Director-General of 
the World Health Organisation, believes the world is moving to a “post-antibiotic 
era”, in which “things as common as strep throat or a child’s scratched knee could 
once again kill” (Public Health England, 2016). 
Economist Jim O’Neill chaired the 2016 Review of Antimicrobial Resistance. Within 
his report, he stated that not only does this phenomenon present a risk to the quality 
and longevity of life but there is also an economic impact. He stated that not acting 
could cost the global economy $100 trillion. Out of a ten-point intervention plan, he 
pointed out four of high importance: the need to develop a global public awareness 
campaign, development of new antibiotics to replace those that are no longer 
effective, reduction of the unnecessary prescription of antibiotics for both humans 
and animals and a decrease in the extensive antibiotic use in agriculture (AMR, 
2016). Antibiotic consumption in England had increased by 6.5% from 2011-2014, 
with the defined daily dose (DDD) per 1000 people rising from 21.6 to 23 in that time 
frame (Public Health England, 2015). 
There has been a sharp decline in the development of new antibiotics in recent 
years and a large contributing factor is the departure of large pharmaceutical 
companies from antibiotic development, supposedly due to the lack of incentive. 
Antibiotics are expensive to discover and develop, require an overly complex but 
necessary regulatory procedure and return less revenue compared to medication 
for chronic conditions such as cancer and diabetes (Sabtu et al, 2015). Nowadays, 
due to antibiotic resistance, they are used as a last resort medication, meaning the 
companies often lose patency of the antibiotic before the cost incurred to develop 
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the drug can be recovered.  The last class of antibiotics to be discovered was 
lipopeptides by Eli Lilly and Company in the early 1980s, with daptomycin (figure 1), 
a Gram-positive bactericidal, approved by the Food and Drug Administration (FDA) 
in 2003 (Pirri et al, 2009).  
 
 
 
 
The need to develop new classes of antibiotics that are able to act against both 
Gram-positive and Gram-negative bacteria is becoming increasingly important. This 
need coincides with an increase in the occurrence of multi-drug resistance bacterial 
strains. In Europe, an estimated 25,000 people die every year as a result of 
nosocomial infections caused by the following bacteria: Escherichia coli, Klebsiella 
pneumoniae, Enterococcus faecium, Pseudomonas aeruginosa and Methicillin-
resistant Staphylococcus aureus (Public Health England, 2015). However, the issue 
lies particularly with Gram-negative bacteria as reports of multi-drug resistance are 
occurring at a faster rate in these bacteria, especially Enterobacteriacecae and P. 
aeruginosa (Sabtu et al, 2015). Efforts are being made to increase awareness of the 
issue as well as implementation of programmes like Infectious Disease Society of 
America’s 10x’20 initiative, aimed at developing ten antibacterial agents by 2020, 
effective against the “ESKAPE” group of microbes: Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, 
Pseudomonas aeruginosa, and Enterobacter species (IDSA, 2010). In addition, 
grants such as the Longitude Prize, where a public vote determined the outcome of 
Figure 1: Daptomycin 
Image source: Micklefield (2004)  
 
       
3 
directed research, was dedicated to overcoming antimicrobial resistance (Longitude 
Prize, N.D).  
 
Historically, infections have been treated using natural products such as bark and 
leaves from trees with reports of ancient civilizations such as the Greeks and 
Egyptians using mixtures containing milk, honey and plant resins as wound 
dressings (Shah, 2011). Natural products have been the inspiration behind many 
antibiotics. Arsphenamine (figure 2), the first synthetic antibiotic, was produced by 
Paul Ehrlich and Sahachiro Hata in 1909 but it was derived from arsenic, a chemical 
element and a naturally occurring metalloid (Frith, 2013).  
 
 
 
 
Nature is once again becoming the source of inspiration behind the development of 
new medication, including novel antibacterial agents. In recent times, chalcones 
have been the subject of increasing interest in the realm of medicinal chemistry as 
they have been discovered to display a plethora of biological potential including 
antimicrobial activity.  Chalcones are well-known molecules in natural product 
chemistry as they have been repeatedly isolated and examined in a bid to 
understand the chemical basis for herb-based medication. Their synthesis has been 
proven to be relatively straightforward and able to produce a range of biologically 
active molecules that can be modified, furthering the understanding of the 
pharmacophore of the compound.  
Chalcones are molecules consisting of two phenyl rings held together by a 3-carbon 
ketone moiety bearing an α-β unsaturated bond (figure 3).  
 
 
Figure 2: Arsphenamine 
Image source: author’s own 
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They were first discovered by Albert-Szent-Gyorgyi after he discovered “vitamin P”, 
a term formally used to describe flavonoids (Grzybowski et al, 2013). Flavonoids are 
a family of polyphenolic compounds that are responsible for a number of plant-
based activities such as regulating cell growth (Higdon, 2016). Chalcones are 
interesting compounds due to their highly conjugated electron system and the 
presence of the unsaturated ketone moiety, which is believed to be the sole provider 
of a chalcone’s biological activity.  
In this project, various parts of the chalcone were modified in order to establish what 
exact substituent the compound must bear in order to be biologically active. Varying 
functional groups were added to the chalcone’s structure in order to ascertain 
whether electron density has a part in its efficacy. The seemingly essential ketone 
was also altered to bear a sulphur instead of an oxygen. Sulphonamides are already 
an established class of antibiotics and so the effectiveness of the sulphonamide 
functional group is well known but this does not apply directly to the possible 
functionality of a thiochalcone or more specifically, the thione functional group. The 
findings of these alterations will be discussed further in this dissertation.  
 
1.1 Literature Review  
This review aims to shed light on the two subject areas this research project 
examines: the synthesis of biologically active chalcones and the need for the 
development of new antimicrobial agents to combat antimicrobial resistance. The 
literature discusses varying techniques to synthesise chalcones as well as the effect 
of different substituents on the compounds’ antimicrobial activity. In this research 
project, modification attempts were made to the pharmacophore of the chalcone. 
The oxygen atom of the ketone moiety was converted to a sulphur atom by way of 
Figure 3: Chalcone (IUPAC: 1,3-diphenyl-prop-2-en-1-
one) 
Image Source: author’s own 
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thionation using Lawesson’s Reagent. This review also briefly discusses 
Lawesson’s Reagent and its previous use in the conversion of chalcones to 
thiochalcones. There is a limited array of literature available in regards to the 
synthesis of thiochalcones but there is little to no data available regarding the 
biological activity of these compounds. However, in a bid to help understand the 
possible activity of these compounds, sulphur-containing compounds that are of a 
similar structure to thiochalcones have been studied. Also, by-products of the use 
of Lawesson’s Reagent are usually phosphorus-containing compounds. Such 
compounds have been reviewed for the purpose of this literature review. 
1.1.1 Biosynthesis of Naturally Occurring Chalcones 
Chalcones are the biosynthetic precursors of flavonoids, a family of polyphenolic 
compounds involved in a number of cell-signalling cascades in plants. The 
biosynthesis of chalcones is conducted via the polyketide pathway. This begins with 
the condensation of one molecule of 4-coumaroyl-CoA and three molecules of 
malonyl-CoA to form an intermediate. This intermediate undergoes a Claisen-like 
cyclization to give naringenin chalcone (scheme 1) (Zhuang et al, 2017). This 
reaction is catalysed by chalcone synthase (Dao et al, 2011). Chalcone synthase is 
classed as a polyketide synthase enzyme (PKS). 
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PKSs are classed into three different groups based on their sequences, primary 
structures and catalytic mechanisms (Yu et al, 2012). Chalcone synthase belongs 
to the superfamily PKS III. This enzyme is omnipresent in the plant kingdom, proving 
Scheme 1: Biosynthesis of naringenin 
chalcone  
Image source: Springbob et al, 2003 
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the importance of its products to the functionality of plants. Chalcones are normally 
distributed within various fruits and vegetables especially apples, citrus fruits, 
potatoes, tomatoes and bean sprouts (Orlikova, 2011), providing insight for the 
success of herbal medicine in the treatments of various ailments including 
infections. Chalcones have also been linked to providing the yellow pigment in 
flowers from the genera Dahlia, Coreopsis and Cosmos (Iwashina, 2000) and the 
families Asteraceae, Moraceae, Fabaceae and Aristolochiaceae (Diáz-Tielas et al, 
2016).  
1.1.2 Synthesis 
 
Chalcone synthesis can be achieved using a variety of techniques including Suzuki 
coupling, Friedal-Crafts acylation and Claisen-Schmidt condensation. Claisen-
Schmidt condensation is the most commonly used method. This reaction is well-
known in organic chemistry. It involves a suitable benzaldehyde and acetophenone 
using a strong acid or base catalyst in a polar solvent, typically methanol (scheme 
2).  
 
 
 
 
 
This reaction is known to produce a mixture of the desired product, by-products and 
starting material, causing variations in the yields of the reactions. However, it is the 
most popular method for chalcone synthesis due to its straightforward procedure 
and relatively efficient formation of the carbon-carbon double bond. The mechanism 
for the base-catalysed reaction is as follows: an enolate ion is formed from the 
removal of an α-hydrogen by a base. This enolate, formed from the reacting ketone, 
reacts with the aldehyde as ketones are less reactive toward nucleophilic addition. 
This intermediate will undergo dehydration which results in the chalcone (scheme 
3).  
Scheme 2: Claisen-Schmidt Condensation Reaction of 
Chalcones 
Image Source: author’s own 
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Reaction conditions are usually room temperature and 1 atmosphere but the 
reaction can also be conducted under warmer conditions such as 40-60°C. There 
have been many reports of synthesis using microwave irradiation. Ahmad et al 
reported the synthesis of a series of 2-acetyl hetero chalcones using microwave 
radiation under 180 watts (Ahmad et al, 2016). 
In terms of the conversion of chalcones to thiochalcones, the most commonly used 
methodology to date requires the use of Lawesson’s Reagent (figure 4). This 
reagent was developed in 1978 by Lawesson and his co-workers (Krstić et al, 2010). 
 
 
Figure 4: Lawesson’s Reagent (IUPAC: 2,4-Bis(4-methoxyphenyl)-2,4-
dithioxo-1,3,2,4-dithiadiphosphetane). 
Image Source: author’s own 
Scheme 3: Chalcone Synthesis 
Mechanism 
Image Source: author’s own  
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The reaction is typically carried out under nitrogen and refluxed or in open air without 
using reflux but at warm temperatures in anhydrous toluene or tetrahydrofuran 
(THF) (scheme 4). Its use in the conversion of chalcones to thiochalcones is 
underreported and available data varies greatly in their reports of yield and purity. 
However, it is often seen that the reaction produces a mixture of the desired product, 
sulphur and phosphorous-containing by-products as well as starting material (Krstić 
et al, 2010). 
 
 
Previous procedures to thionate organic compounds utilised phosphorous 
pentasulfide (P4S10), first reported in 1869 by Henry and Wislicenus (Cava, 1985) 
but its procedure required very large amounts of this reagent and long reaction times 
to produce low yields. Lawesson’s Reagent is a more favourable converting reagent 
due to its availability, ease of use and a relatively straightforward reaction. 
1.1.3 Effects of Substituents on Activity & Pharmacophore 
It has been suggested that adding substituents on either the A or B ring of the 
chalcone may influence its biological activity. However, the α-β unsaturated ketone 
moiety is regarded to be the main pharmacophore of a chalcone as its removal has 
resulted in either a major reduction or complete loss of antimicrobial activity 
(Batovska et al, 2010). In regards to antimicrobial activity, certain substituents are 
favoured more than others. As seen in the Tran et al study, chalcones with two or 
three methoxy groups on the B ring are inactive regardless of substituents on the A 
ring (refer to figure 3 for labelling and positioning) (Tran et al, 2012). It is suggested 
that more than two methoxy groups on the B ring eradicate the hydrophilic property 
of a chalcone which allows for penetration through the bacterial cell wall (Tran et al, 
2012). This was reflected in results obtained by Baba et al, who reported 
Scheme 4: Conversion of Chalcone to Thiochalcone using Lawesson’s 
Reagent 
Image source: author’s own 
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synthesising a series of trimethoxy-substituted chalcones but when tested, no 
antimicrobial activity was shown (Baba et al, 2013) (figure 5). 
 
 
 
 
Electron-donating groups such as a hydroxyl group have been seen to increase the 
antimicrobial activity of a chalcone, but hydroxyl groups are also hydrophilic. A free 
hydroxyl group on the B ring at position 4 or 6 is important for methicillin-resistant 
Staphylococcus aureus (MRSA) activity (Ávila et al, 2008) (figure 6). 
 
 
 
 
 
A degree of importance is attached to the positioning of the hydroxyl group: the meta 
position brought about a diminished level of activity (100g/ml against B.subtilis) 
when compared to the ortho position (50g/ml against B.subtilis) (Silva et al, 2013) 
(figure 7).  
 
 
Figure 5: 1-(3’, 4’, 5’-trimethoxyphenyl)-3-(3, 4, 5-
trimethoxyphenyl)-prop-2-ene-1-one 
Image source: Baba et al (2013) 
Figure 6: 4-Hydroxyderricin 
Image source: Ávila et al (2008)  
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Avila et al concluded from their study that a free hydroxyl group on the B ring is 
necessary for any antimicrobial activity as this activity is lost once it is substituted 
(Ávila et al, 2008). Weakly electron-donating groups such as halogens (chlorine, 
fluorine, bromine) have been seen to positively contribute to the antimicrobial activity 
of a chalcone as well. Halogens are naturally electron-withdrawing by way of 
induction but can also be electron-donating due to the lone pair of electrons they all 
bear.  
Nielsen et al synthesised a series of compounds, including a pair of chalcones 
bearing a (3, 5)-dibromo substituent and (2, 4, 6)-trifluoromethyl substituents on the 
B rings of their respective compounds, shown below (Nielsen et al, 2004) (figure 8).  
 
 
 
 
 
These compounds showed promising activity as did a chalcone synthesised by 
Karthikeyen et al (2007), which had (4, 6)-dichloro and (3)-fluoro substituents on the 
A ring (figure 9).  
 
 
Figure 7: 1-phenyl-3-(3-hydroxyphenyl)-prop-2-ene-1-
one (hydroxyl group shown in ortho position) 
Image source: Silva et al (2013) 
Figure 8: substituted hydroxychalcone (R representing 
dibromo or trifluoromethyl substituents) 
Image source: Yazdan et al (2015) 
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Mohamed et al (2003) converted a series of steroidal ketones to their thioxo 
equivalents using Lawesson’s Reagent and tested the compounds for antimicrobial 
and antifungal activity (figure 10). They followed a standard procedure of using 
anhydrous toluene under reflux and isolated the compound using column 
chromatography. Four of the compounds displayed activity against both Gram-
positive and Gram-negative bacteria including B. subtilis, P. aeruginosa and E.coli 
at 200µg/ml.  
 
 
 
 
 
Ahmed et al (2015) reported the synthesis of a series of sulfides, their corresponding 
bis-sulfides and sulfones. They were tested for their antimicrobial activity and they 
all displayed activity against a variety of Gram-negative and Gram-positive bacteria 
including B. subtilis and S. aureus at varying concentrations of 3.9-31.25µg/ml. A 
particular sulfone with a 3-NH2 position on the A ring (figure 11) displayed a higher 
level of activity compared to chalcones with chloro, methyl and trimethoxy 
substituents against S. aureus.  
Figure 9: 3-aryl-1-(2’,4’-dichloro-5’-fluorophenyl)-2-propen-
1-one 
Image source: Khadar-Yazdan et al (2015)  
Figure 10: 3β-mercaptospiro(androstan-17, 4-
dithiaphosphetan)thione 
Image source: Mohamed et al 
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However, the study failed to state whether this higher level of activity was due to the 
presence of the sulphur-containing groups or substituents on the rings of the 
compounds.  
 
Vanangamudi et al (2013) synthesised a series of 2,5-dimethyl-3-thienyl chalcones 
via a Claisen-Schmidt condensation reaction. All the compounds showed activity 
against the bacteria tested including P. aeruginosa, B. subtilis and E. coli. In this 
study, they attributed the improved activity of the compounds to the methoxy, methyl 
and nitro substituents in the 3rd position on the B ring (figure 12). 
 
 
 
 
 
 
Figure 11: 1-(2’-aminophenyl)-3-(4-methylphenyl)-3 
(phenylsufonyl)propan-1-one 
Image source: Ahmed et al (2015) 
 
Figure 12: substituted styryl 2’,5’-dimethyl-3-thienyl ketone (R 
representing methoxy, methyl and nitro substituents) 
Image source: Vanangamudi et al (2017) 
 
       
14 
In all this, structure-activity relationships still fail to adequately identify what exact 
part of a chalcone is responsible for its biological activity and the notion that the α-
β unsaturated ketone system is the sole proprietor of this activity is challenged in 
this research project by the exchange of the ketone’s oxygen with a sulphur atom.  
 
1.1.4 Antimicrobial Activity of Phosphorous-Containing Compounds 
As mentioned before, the use of Lawesson’s reagent to convert chalcones to 
thiochalcones produces a mixture of compounds including phosphorous-containing 
by-products. It is important to understand the effect these compounds may have on 
antimicrobial activity as they may alter that of the synthesised compounds.  
Moenomycins are a family of phosphorous-containing antibiotics (Ostash et al, 
2010). They are produced by Streptomyces, a genus of bacteria that produces a 
majority of antibiotics of natural origin such as chloramphenicol and neomycin 
(Aínsa et al, 2000). They are classed as phosphoglycolipids due to their chemical 
composition and have been known to have a very complex structure with an even 
more complex synthesis (Ostash et al, 2010). The class was first discovered in the 
1960s (figure 13) and was shown to have high levels of activity against Gram-
positive bacteria (Halliday et al, 2006) but interest in its potential as antibiotics 
dwindled due to its poor pharmacokinetic properties – it was found to be cytotoxic 
at concentrations of 10µg/ml and higher (Ostash et al, 2010). Instead, it was 
commercialised as an antimicrobial growth promoter in animal feeds (Halliday et al, 
2006). However, a European Union (EU)-wide ban on antimicrobial growth 
promotors came into effect on 1 January 2006 (European Commission, 2005). 
 
 
 
Figure 13: Moenomycin A 
Image Source: Ostash et al, 2010 
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Reddy et al synthesised a series of phosphorous heterocycles with an exocyclic P-
C link. 2-(20-Chloroethyl)-2,3-dihydro-5-benzoyl-1H-1,3,2-benzodiazaphosphole-2-
Oxide (figure 14) was found to be active against both S. aureus and E. coli at 250µg 
and 500µg, producing zones of inhibition of 6-9mm and 4-8mm respectively (Reddy 
et al, 2004).  
 
 
Polyphosphates are salts formed from repeating units of phosphate units. They are 
utilised as a food additive by the FDA to prevent food spoilage (Moon et al, 2011). 
Inorganic polyphosphate is found widespread in all organisms as it can serve as an 
adenosine triphosphate (ATP) source. However, an external source of 
polyphosphate has shown antimicrobial activity against many Gram-positive 
bacteria including S.aureus. Its mode of action is thought to include the inhibition of 
certain stages of cell wall synthesis (Moon et al, 2011).  
 
 
 
 
 
 
Figure 15: Polyphosphate 
Image source: Morrisey et al, 2012 
Figure 14: 2-(20-Chloroethyl)-2,3-dihydro-5-benzoyl-1H-1,3,2-
benzodiazaphosphole-2-Oxide 
Image Source: Reddy et al, 2004 
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1.1.5 Antimicrobial Resistance 
Microorganisms can either be inherently resistant to an antibiotic or develop 
resistance after persistent exposure, this is known as acquired resistance. This 
acquired resistance could arise by either mutation or a transfer of a resistance 
mechanism programmed on genes (Sabtu et al, 2015). This horizontal gene transfer 
can occur through three different mechanisms: conjugation, transformation or 
bacteriophage-mediated transduction (Arber, 2014). Antimicrobial resistance could 
be viewed as an inevitable result of antibiotic use but the issue has been 
exacerbated due to the systematic abuse of this medication both in and outside 
healthcare settings (Sabtu et al, 2015). Also, in this era of modern travel and the 
inevitability of human contact, an antimicrobial-resistant strain could be easily 
spread in a very short amount of time. For example, the New Delhi metallo-β-
lactamase-1 (NDM-1) carbapenamese enzyme found in some species of 
Enterobacteriaceae was first detected in Sweden after a patient from India had been 
transferred for medical reasons (Kumarasamy et al, 2010). 
As mentioned earlier, the ESKAPE pathogens are the leading cause of nosocomial 
infections such as blood infections, urinary tract infections and wound infections 
(Higuita et al, 2014) and largely contribute to the issue of antimicrobial resistance 
due to the scale of their combined multi-drug resistance. The organisms include 
both Gram-negative and Gram-positive whose main structural difference is the 
makeup of their cell envelopes. They both possess peptidoglycans in their cell walls 
which provide their characteristic cell shape; Gram-positive bacteria has a thick cell 
wall whilst Gram-negative bacteria has a thin cell wall. Despite having lower levels 
of peptidoglycan, Gram-negative bacteria possess a more complex cell envelope 
structure (Salton et al, 1996). This complexity makes Gram-negative bacteria harder 
to penetrate, thus more difficult to target using antimicrobial agents.  
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The outer membrane of Gram-negative bacteria contains a high lipopolysaccharide 
complex content (Rietschel et al, 1994). This lipopolysaccharide complex is 
multifunctional: it acts as a barrier to lysosomes and to certain antimicrobial agents 
as well as acting as an adhesive agent in some Gram-negative bacteria to ensure 
colonization of its host (Wang et al, 2010). When a bacterial cell is lysed by the 
immune system through phagocytosis, the polysaccharide fragments. These 
sections bear Lipid A, a moiety that acts as an endotoxin, initiates an inflammatory 
response in animals that could result in fatal endotoxic shock, also known as septic 
shock (Tzeng et al, 2002). Therefore, besides the initial difficulty of attacking the cell 
wall of Gram-negative bacteria, attacking the cell may result in the release of the 
endotoxin whose action could be fatal.  
In this project, the bacteria Escherichia coli (E. coli), Pseudomonas aeruginosa (P.  
aeruginosa) and Staphylococcus epidermidis (S. epidermidis) were utilised to test 
the synthesised compounds’ activity against both Gram-negative and Gram-positive 
bacteria.  
E. coli is a rod-shaped, Gram-negative bacterium of the Enterobactericeae family. It 
is a facultative anaerobic bacteria, meaning it produces ATP for respiration in the 
presence of oxygen but has the ability to respire anaerobically in the absence of 
oxygen (Stieglmeier et al, 2009). This bacteria is typically found in the lower intestine 
of warm-blooded organisms but some strains such as Verocytotoxin-producing E. 
coli (VTEC) or enterohaemorrhagic E. coli (EHEC) are pathogenic, causing illnesses 
Figure 16: Differences in Cell Envelope Structure – Gram-negative vs 
Gram-positive bacteria 
Image Source: Brown et al, 2015 
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associated with food and water contamination (Karmali et al, 2010). In Germany of 
2011, there was an outbreak of a food-borne infection caused by EHEC, leading to 
large numbers of people falling ill with cases of bloody diarrhoea and haemolytic-
uremic syndrome (Burger, 2012), a disease that causes severe inflammation of 
blood vessels and formation of blood clots throughout the body (NHS England, 
2017). During the 5-month long outbreak, approximately 3000 cases of EHEC-
associated infections were seen with 855 of these cases developing to haemolytic-
uremic syndrome. Prior to this outbreak, there were approximately 1000 cases of 
EHEC-associated infections per year with 70 of these cases developing to 
haemolytic-uremic syndrome (Burger, 2012). Upon investigation by the German 
authority for food safety, it was found that the origin of this outbreak was in a 
contaminated batch of sprouts, with EHEC isolated in the stool of infected patients 
(Burger, 2012).  
P. aeruginosa is a Gram-negative, rod-shaped bacterium of the 
Pseudomonadaceae family. It is also a facultative anaerobe with the ability to 
survive in an array of environmental conditions (Wu et al, 2015). It is an opportunistic 
pathogen as it tends to exploit a host that is in a weakened state i.e. immune-
deficient, wounded and ageing (Brown et al, 2015). P. aeruginosa is known to cause 
chronic lung infections in patients with cystic fibrosis and skin infections in severely 
burned patients (Colmer-Hamood et al, 2016). In the summer of 2018, a human milk 
bank in Northern Ireland had to be suspended as P. aeruginosa was found in the 
water supply of the milk bank’s hospital (BBC, 2018). Previously, four premature 
babies died in the Royal Maternity Hospital in Belfast due to an infection caused by 
the bacteria that was later found to be borne in the hospital’s water supply as well 
(BBC, 2012).  
S. epidermidis is a Gram-positive, spherical bacterium of the Staphylococcaceae 
family. It is also facultatively anaerobic and is a member of human skin flora but still 
has the ability to become pathogenic, being the cause of a significant number of 
nosocomial infections (Namvar et al, 2014). It is known that infections caused by 
this bacterium begin with its introduction during device insertion such as needles 
breaking the surface of the skin (Otto, 2009). In the United States, S. epidermidis is 
the cause of 22% of blood infections (NNIS, 2004). Even though S. epidermidis 
causes infections that are not easy to treat, they do not cause life-threateningly 
dangerous infections (Otto, 2009) such as the aforementioned bacteria.  
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1.2 Aim 
The aim of this project was to synthesise  a series of chalcones from a combination 
of substituted acetophenones and benzaldehydes using a reliable methodology, 
including the use of Lawesson’s Reagent to convert these chalcones to 
thiochalcones, in an attempt to alter the pharmacophore of the compound. The aim 
also includes establishing any antimicrobial activity of the compounds and 
investigating said activity further. The synthesis and biological activity of 
thiochalcones is not heavily reported. The following table itemises the structures of 
the compounds this project aimed to synthesise:  
Table 1: IUPAC Names and Chemical Structures of Proposed Compounds 
IUPAC Name/Code Chemical Structure 
1 - 1-(2’-acylpyrrole)-3-(4-
chlorophenyl)-prop-2-
ene-1-one 
 
2 - 1-(3’,4’-
dichlorophenyl)-3-(2,4,6-
trimethoxyphenyl)-prop-2-
ene-1-one 
 
3 - 1-(2’,4’-
dichlorophenyl)-3-(4-
methoxyphenyl)-prop-2-
ene-1-one   
4 - 1-(2’,4’-
dichlorophenyl)-3-(4-
hydroxyphenyl)-prop-2-
ene-1-one   
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5 - 1-(2’-acetylfuran)-3-(4-
chlorophenyl)-prop-2-
ene-1-one 
 
6 - 1-(4’-aminophenyl)-3-
(4-chlorophenyl)-prop-2-
ene-1-one  
 
7 - 1-(4’-bromophenyl)-3-
(4-chlorophenyl)-prop-2-
ene-1-one  
 
8 - 1-(4’-fluorophenyl)-3-
(4-chlorophenyl)-prop-2-
ene-1-one  
 
9 - N-(4-
bromobenzylidene)-4’-
acetoaniline 
 
10 - 1-(2’,4’-
dichlorophenyl)-3-(2, 4, 6-
trimethoxyphenyl)-prop-2-
ene-1-one  
 
11 - 1-(4’-fluorophenyl)-3-
(4-chlorophenyl)-prop-2-
ene-1-thione 
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12 - 1-(2’,4’-
dichlorophenyl)-3-(4-
methoxyphenyl)-prop-2-
ene-1-thione  
13 - 1-(4’-bromophenyl)-
3-(4-chlorophenyl)-prop-
2-ene-1-thione 
 
14 - N-(4-
bromobenzylidene)-4’-
thioaniline 
 
15 - 1-(tert-
butoxycarboxylleucine)-3-
(4-chlorophenyl)-prop-2-
ene-1-one 
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2. Methodology 
2.1 Materials  
All chemical reagents and solvents utilised were sourced from both Sigma-Aldrich 
and Alfa-Aesar unless otherwise stated. All agar powders and antibiotics used 
during the microbiology section of this project were sourced from Thermo Fischer 
Scientific.  
Table 2: List of reagents available for synthesis of chalcones and thiochalcones 
Reagents 
2-hydroxy-4-methoxybenzaldehyde 4-chloroacetophenone 
2,4,6-trimethoxybenzaldehyde 3,4-dichloroacetophenone 
Salicylaldehyde 2,4-dichloroacetophenone 
4-bromobenzaldehyde Gallacetophenone 
4-hydroxybenzaldehyde 2-acetylfuran 
4-chlorobenzaldehyde 2-acetylpyrrole 
5-bromo-3-nitrobenzaldehyde 2-hydroxy-3-nitrobenzaldhyde 
3,4-dihydroxybenzaldehyde 5-bromo-3-flurosalicyladehyde 
3,4-dihydroxybenzaldehyde 4-methoxybenzaldehyde 
Sodium/lithium/potassium hydroxide Lawesson’s reagent 
 
Table 3: List of solvents used during synthesis of chalcones and thiochalcones 
Solvents 
Dichloromethane (DCM) Methanol 
Anhydrous N,N-dimethylformamide 
(DMF) 
Deuterated dimethyl sulfoxide 
(DMSO) 
Ethyl acetate Deuterated chloroform 
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Anhydrous tetrahydrofuran (THF) Deuterated methanol 
Anhydrous toluene Distilled water 
Hexane  
 
Table 4: List of materials used in microbiology testing 
Materials 
Nutrient agar (Oxoid, CM0003) Distilled water 
Mueller-Hinton agar (Oxoid, CM0337) 
Ciprofloxacin discs (10µg) (Oxoid, 
CT1615) 
Mueller-Hinton broth (Oxoid, CM0405) 
Ringer’s Solution Tablets (Oxoid, 
BR0052) 
Dimethyl sulfoxide (DMSO) (molecular 
biology grade) (Sigma-Aldrich, D8418) 
 
 
Chemical reagents were used without purification. A 1 M solution of sodium 
hydroxide was made by dissolving 4g of sodium hydroxide pellets in 100ml of 
distilled water. 1H and 15P Nuclear Magnetic Resonance (NMR) were recorded at 
400MHz and 162 MHz respectively and 13C at 100MHz on a Varian 400MHz system 
with Oxford NMR As400 Magnet in deuterated chloroform, DMSO or methanol at 
room temperature. Infra-red (IR) spectroscopy data was recorded on a Thermo-
Scientific Nicolet iS5 FTIR Spectrometer. Gas Chromatography Mass Spectrometry 
(GCMS) data was recorded on an Agilent 5975C Series GC/MSD System. 
Reactions were monitored by thin layer chromatography (TLC) using EMD Millipore 
TLC Silica gel 60 plates and a solvent system consisting of various ratios of hexane, 
dichloromethane and ethyl acetate. The plates were visualised under an ultraviolet 
(UV) lamp at 254nm. Column chromatography was carried out using either silica, 
Sephadex™ or alumina. Mobile phase systems were mixtures of laboratory grade 
solvents utilised during TLC. All agars, solutions and broths used were prepared 
according to the manufacturer’s instructions and autoclaved before their use. Petri 
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dishes and 96-well plates sourced from Thermo-Scientific were sterile upon 
purchase.  
 
2.2 Chemistry – Experimental procedures 
2.2.1 Synthesis of 1-(2’-acylpyrrole)-3-(4-chlorophenyl)-prop-2-ene-1-one (1) 
 
4-chlorobenzaldehyde (0.54 g, 3. mmol) and 2-acetylpyrrole (0.74 g, 6.8 mmol) were 
dissolved in methanol (10 ml) in a round-bottomed flask and stirred at 65°C until the 
dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-3 ml) was added 
and the solution slowly became bright yellow. This was left to stir for 40 minutes. 
The colour of the solution was yellow. The solution was left to cool before water was 
added (approx. 5 ml), resulting in the precipitation of the compound. This precipitate 
was washed with water and filtered under vacuum. Pale yellow crystals were 
isolated. The crystals were dried in a vacuum oven at 60°C. 
2.2.2 Synthesis of 1-(3’, 4’-dichlorophenyl)-3-(2, 4, 6-trimethoxyphenyl)-prop-
2-ene-1-one (2) 
 
2, 4, 6-trimethoxybenzaldehyde (1.04 g, 5.3 mmol) and 3,4-dichloroacetophenone 
(0.95g, 5.04 mmol) were dissolved in methanol (10 ml) in a round-bottomed flask 
and stirred at 65°C until the dissolution of the reagents. A solution of sodium 
hydroxide (1 M, 2-3 ml) was added and an instantaneous colour change was 
noticed, with the solution becoming bright yellow. The solution was left to stir for 30 
minutes. A precipitate had already formed upon returning. The mixture was taken 
off heat and left to cool. Water (approx. 5 ml) was added into the mixture and it was 
noted that more precipitate seemed to form. The precipitate was filtered under 
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vacuum, resulting crystals were neon yellow. They were dried in a vacuum oven at 
60°C for 30 minutes.  
2.2.3 Synthesis of 1-(2’, 3’-dichlorophenyl)-3-(4-methoxyphenyl)-prop-2-ene-1-
one (3) 
 
4-methoxybenzaldehyde (0.74 g, 5.3 mmol) and 2, 4-dichloroacetophenone (0.95g, 
5.0 mmol) were dissolved in methanol (10 ml) in a round-bottomed flask and stirred 
at 65°C until the dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-
3 ml) was added and the solution turned yellow. It was left to stir for 30 minutes. A 
precipitate had already formed without the addition of water and no more formed 
when approximately 5 ml was added. The resulting precipitate was filtered under 
vacuum and dried in a vacuum oven at 60°C. The crystals were yellow in colour. 
2.2.4 Synthesis of 1-(3’,4’-dichlorophenyl)-3-(4-hydroxyphenyl)-prop-2-ene-1-
one (4) 
 
4-hydroxybenzaldehyde (0.64 g, 5.3 mmol) and 3, 4-dichloroacetophenone (0.95 g, 
4.9 mmol) were dissolved in methanol (10 ml) in a round-bottomed flask and stirred 
at 65°C until the dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-
3 ml) was added but no colour change was noticed at this point. The solution was 
left to stir for 30 minutes. Upon returning, the solution remained unchanged and was 
left to stir for an extra 30 minutes. At this point, the solution appeared yellow but 
translucent. It was taken off the heat and left to cool. Concentrated sulphuric acid 
was added (2-3 ml) which resulted in the solution turning red but after continuous 
stirring, it returned to its yellow colour.  The product was extracted with 
dichloromethane (10 ml) and the solvent was removed under reduced pressure. Not 
all the solvent was removed but a precipitate had begun to form. This mixture was 
cooled on ice and a very deep yellow precipitate formed. The mixture was placed 
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on the vacuum line to be dried for a total of 5 hours. The precipitate was analysed 
using 1H NMR and was seen to be starting material. However, the aqueous layer 
had been retained and upon removal of the solvent, a dark yellow solid was 
obtained. This solid was dried in a vacuum oven for 3 hours at 30°C. 
2.2.5 Synthesis of 1-(2’-acetylfuran)-3-(4-chlorophenyl)-prop-2-ene-1-one (5) 
 
4-chlorobenzaldehyde (0.57g, 4.1 mmol) and acetylfuran (0.43g, 3.9 mmol) were 
dissolved in methanol (10 ml) in a round-bottomed flask and stirred at 45°C until the 
dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-3 ml) was added 
and the solution turned pale red. It was left to stir for 15 minutes and a precipitate 
formed. The resulting precipitate was washed with water, filtered under vacuum left 
to air dry in a locker overnight. The crystals were off-white and flaky. 
2.2.6 Synthesis of 1-(4’-aminophenyl)-3-(4-chlorophenyl)-prop-2-ene-1-one 
(6) 
 
4-chlorobenzaldehyde (0.71g, 5.1 mmol) and 4-aminoacetophenone (0.72 g, 5.3 
mmol) were dissolved in methanol (10 ml) in a round-bottomed flask and stirred at 
65°C until the dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-3 
ml) was added and an immediate colour change was noticed with the solution 
turning deep orange before slowly becoming bright yellow. It was left to stir for 30 
minutes and a precipitate crashed out without the addition of water. Water (10 ml) 
was added but it did not appear to affect the precipitate nor encourage more of its 
formation. This was filtered under vacuum. The crystals formed were bright yellow. 
They were dried in a vacuum oven at 60°C. 
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2.2.7 Synthesis of 1-(4’-bromophenyl)-3-(4-fluorophenyl)-prop-2-ene-1-one 
(7) 
 
4-fluorobenzaldehyde (0.8 ml, 6.4 mmol) and 4-bromoacetophenone (0.99 g, 4.9 
mmol) were dissolved in methanol (10ml) in a round-bottomed flask and stirred at 
50°C until the dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-3 
ml) was added and a slight colour change was noticed, the solution became a very 
pale yellow. A few moments later, a precipitate had formed without the addition of 
water. This was filtered under vacuum. The resulting crystals were pale yellow. They 
were dried in a vacuum oven at 50°C. 
2.2.8 Synthesis of 1-(4’-fluorophenyl)-3-(4-chlorophenyl)-prop-2-ene-1-one (8) 
 
4-chlorobenzaldehyde (0.75 g, 5.3 mmol) and 4-fluoroacetophenone (0.78 ml, 5.6 
mmol) were dissolved in methanol (10 ml) in a round-bottomed flask and stirred at 
50°C until the dissolution of the reagents. A solution of sodium hydroxide (1 M, 2-3 
ml) was added and the solution became pale yellow. A few moments later, a 
precipitate formed without the addition of water. This was filtered under vacuum and 
the white crystals were dried in a vacuum oven at 50°C. 
2.2.9 Synthesis of N-(4-bromobenzylidene)-4’-acetoaniline (9) 
 
4-bromobenzaldehyde (2.8 g, 15.1 mmol) and 4-aminoacetophenone (2.1 g, 15.5 
mmol) were dissolved in methanol (10 ml) in a round-bottomed flask and stirred at 
 
       
28 
60°C until the dissolution of the reagents. Without the addition of the sodium 
hydroxide solution, the precipitate began to form. The reaction mixture was left to 
stir for 30 minutes. Water (10 ml) was added to see if this would alter anything but 
no change was noticed. The precipitate was filtered under vacuum. Resulting 
crystals were pale yellow and powdery. Instead of drying them in a vacuum oven, 
they were left to air dry in a dark locker.  
2.2.10 Synthesis of 1-(2’,4’-dichlorophenyl)-3-(2,4,6-trimethoxyphenyl)-prop-
2-ene-1-one (10) 
 
2, 4, 6-trimethoxybenzaldehyde (0.73g, 3.7 mmol) and 2, 4-dichloroacetophenone 
(1.01g, 5.3 mmol) were dissolved in methanol (10 ml) in a round-bottomed flask and 
stirred at 65°C until the dissolution of the reagents. A solution of sodium hydroxide 
(1 M, 2-3 ml) was added and a precipitate began to form immediately. This was 
filtered under vacuum. The crystals were left to air dry in a dark locker. 
2.2.11 Synthesis of 1-(4’-fluorophenyl)-3-(4-chlorophenyl)-prop-2-ene-1-
thione (11) 
 
Compound 8 (0.78g, 0.50 mmol) and Lawesson’s Reagent (0.23g, 0.56 mmol) were 
dissolved in anhydrous THF (30 ml, 0.4 mol) in a round-bottomed flask and stirred 
under nitrogen whilst heated at 45°C. The reaction was monitored using TLC until 
the reaction was complete, after approximately 2 hours. The solution became 
orange upon stirring. The solvent was evaporated off using a rotary evaporator, 
resulting in an orange, thick substance. Column chromatography was performed 
using Sephadex™ and a mobile phase of DCM and methanol in a 1:1 ratio. The 
product, a thick orange liquid was left to air dry in a dark locker overnight. This 
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resulted in flaky orange crystals forming. These crystals were stored in a sealed 
glass tube in a cool and dark area until needed. 
2.2.12 Synthesis of 1-(2’,3’-dichlorophenyl)-3-(4-methoxyphenyl)-prop-2-ene-
1-thione (12) 
 
Compound 3 (0.16 g, 0.52 mmol) and Lawesson’s Reagent (0.24 g, 0.059 mmol) 
were dissolved in anhydrous THF (30 ml) in a round-bottomed flask and stirred 
under nitrogen whilst heated at 60°C and left to stir at 30 minutes. The remaining 
THF was evaporated off using a rotary evaporator, resulting in a dark yellow, thick 
oil-like substance. Column chromatography was performed using Sephadex™ and 
a mobile phase of DCM and methanol in a 1:1 ratio. The product, a thick yellow 
liquid was left to air dry in a dark locker overnight. No change was noticed but the 
sample was stored in a glass tube and kept in a dark and cool area until needed. 
2.2.13 Synthesis of 1-(4’-bromophenyl)-3-(4-chlorophenyl)-prop-2-ene-1-
thione (13) 
 
Compound 7 (0.24 g, 0.81 mmol) and Lawesson’s Reagent (0.24 g, 0.059 mmol) 
were dissolved in anhydrous THF (30 ml) in a round-bottomed flask and stirred 
under nitrogen whilst heated at 40°C. This was left to stir for 2 hours and the solution 
appeared slightly yellow. This was taken off the heat and the remaining solvent was 
evaporated using a rotary evaporator. This resulted in a pale yellow solid. This was 
left to dry overnight. The next day, it was noticed the solid had become a yellow 
thick liquid. This was washed with water (10 ml) and extracted using ethyl acetate 
(10 ml). The organic layer was kept and the solvent was evaporated. This step 
produced a yellow thick liquid. Column chromatography was performed using 
Sephadex™ and a mobile phase of 30% dichloromethane, 65% hexane and 5% 
ethyl acetate. The product, also a thick yellow liquid was left to air dry in a dark 
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locker overnight. This was stored in a sealed glass tube in a cool and dark area until 
needed. 
 
2.2.14 Synthesis of N-(4-bromobenzylidene)-4’-acetothioaniline (14)  
 
Compound 9 (0.15 g, 0.49 mmol) and Lawesson’s Reagent (0.20 g, 0.049 mmol) 
were dissolved in anhydrous toluene (30 ml) in a round-bottomed flask and stirred 
under nitrogen whilst heated at 55°C. The solution became red upon stirring and 
was left stirring for a total of 8 hours. Every hour, a TLC was done to monitor the 
progress of the reaction. After 8 hours, there were 2 spots on the TLC meaning 
starting material was still present. The reaction was left to stir overnight. After an 
additional 12 hours, the TLC showed one spot. Remaining solvent was removed on 
the rotary evaporator resulting in a deep purple thick liquid. Column chromatography 
was performed using alumina and a mobile phase of 30% dichloromethane, 65% 
hexane and 5% ethyl acetate. The product, a thick purple liquid was left to air dry in 
a dark locker overnight. This was stored in a sealed glass tube in a cool and dark 
area until needed. 
2.2.15 Synthesis of 1-(tert-butoxycarboxylleucine)-3-(4-chlorophenyl)-prop-2-
ene-1-one (15)  
 
 
An attempt to carry out a DCC/HOBt-mediated coupling of a chalcone with an amino 
acid was made.  
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Compound 6 (1.0 g, 3.9 mmol) and HOBt (0.54 g, 4.0 mmol) were added to chilled 
DCM (30 ml) and stirred on ice for 30 minutes. To this, Boc-Leu-OH (0.93 g, 4.0 
mmol) and DCC (1 ml, 4.4 mmol) were added and the reaction mixture was taken 
off the ice. At room temperature, this mixture was left to stir for 2 hours. This was 
decanted into glass tubes and stored in a freezer overnight. 4% hydrochloric acid 
(30 ml), saturated sodium carbonate solution (25 ml) and brine (30 ml) were added 
consecutively to the reaction mixture. Bubbles evolved at each addition. Calcium 
sulphate, a desiccating agent (approx. 20 g) was added to this mixture and this 
formed clumps at the bottom of the round-bottomed flask. Once the clump forming 
had stopped, it was filtered off from the mixture, leaving a clear solvent with a yellow 
solid at the bottom of the conical flask. The solvent and the solid were separated 
and the solid was oven-dried at 50°C for 30 minutes. This produced a yellow sticky 
solid. Column chromatography was performed using Sephadex™ and a mobile 
phase of DCM and methanol in a 1:1 ratio. The product, also a yellow sticky solid 
was stored in a sealed glass tube in a cool and dark area until needed. 
 
2.3 Microbiology – Experimental 
The microbial strains Escherichia coli (NCTC 7928), Pseudomonas aeruginosa 
(NCTC 6749) and Staphylococcus epidermidis (NCTC 9865) were utilised. 
The initial screening of the synthesised compounds was performed according to The 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
methodology using disk diffusion testing. The bacterial strains were obtained from 
the microbial bank of the Microbiology department of Kingston University. The 
bacteria were grown for 24 hours at 37°C on nutrient agar. The inocula for the 
assays were prepared by cell suspensions in Ringer’s solution (Oxoid UK, Ltd.) to 
give a concentration of approximately 1.5x108 CFU/ml and used within 15 minutes 
of preparation. 
 
2.3.1 Establishing antimicrobial activity 
The compounds were dissolved in DMSO at a concentration of 10 mg/ml. From the 
prepared cultures, the bacteria were spread onto Mueller-Hinton agar plates (4 mm 
depth) using a sterile swab and the Petri dishes were divided into three sections: a 
positive control, a negative control and the synthesised compound. The positive 
control was ciprofloxacin (10 µg), the negative control was 10 µl DMSO and the 
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compound was used in 10 µl doses. Each test was done in duplicates and incubated 
at 37°C for 24 hours. The zones of inhibition produced by the compounds and the 
antibiotic discs were measured in millimetres (mm) and recorded. Once the active 
compounds had been identified, repeat tests were done in triplicate to ensure 
reliability of results.  
2.3.2 Minimum inhibitory concentration (MIC)  
This was determined using the microtitre broth dilution method. 96-well microtitre 
plates were used in this procedure. Mueller-Hinton broth was prepared at double 
and single strength whilst a stock solution of 10 mg/ml of the active compound was 
prepared. A 100 µl aliquot of the double concentration broth was dispensed to the 
first 3 rows of the 96-well plate, followed by 200 µl of the active compound’s stock 
solution into the first well of the first 3 rows. The first well was mixed carefully using 
the pipette before 100 µl was transferred to the next well. Using a sterile tip each 
time, this was repeated a further four times, making a dilution series of the 
compound under test as follows: 5 mg/ml, 2.5 mg/ml, 1.25 mg/ml, 0.625 mg/ml and 
0.3125 mg/ml. The inocula for the wells were prepared as above and a 5 µl aliquot 
of bacteria dispensed in each well using a sterile tip for each addition. The positive 
control was the double concentrated Mueller Hinton broth inoculated with 5 µl of 
bacteria, giving a concentration of approximately 5x105 CFU/ml. The negative 
controls were the double concentrated Mueller Hinton broth with 5 µl DMSO as well 
as single concentrated Mueller Hinton broth on its own. The plates were incubated 
at 37°C for 24 hours. The plates were read by eye and the results were recorded. 
Repeat tests were done in triplicates to ensure reliability.  
2.3.3 Minimum bactericidal concentration (MBC) 
Nutrient agar was used in this procedure and each plate was divided into 8 sections, 
section 1-5 dedicated to the wells of the plates used for determining MIC containing 
the active compound and bacteria whilst section 6-7 were dedicated to the positive 
and negative controls. A sterile swab was used to transfer a small amount from each 
well after the MIC incubation to its corresponding section on the agar. The plates 
were incubated at 37°C for 24 hours. The plates were read and the results were 
recorded. Repeat tests were done in triplicates to ensure reliability. 
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3. Results 
 
A total of fifteen compounds were synthesised: nine chalcones, four thiochalcones, 
a diphenyl-imine compound and a chalcone-amino acid conjugate. Out of these 
fifteen compounds, two of the thiochalcones showed antimicrobial activity whilst 
none of the chalcones showed activity. The chalcone-amino acid conjugate was not 
tested for any activity. The certainty of the synthesis of the thiochalcones is 
addressed in the discussion. 
Table 5: Masses, Melting Points & Percentage Yields of the Synthesised 
Compounds 
Code Mass (g) Melting Point (°C) Percentage yield (%) 
1 1.52 158.8-163.0 100.7 
2 0.96 185.7-187.2 52.3 
3 0.47 84.1-88.7 30.7 
4 2.01 168.2-171.9 138.4 
5 0.51 139.0-143.2 40.2 
6 0.67 - 51.9 
7 1.04 142.9-143.5 64.9 
8 1.23 137.0-141.2 89.5 
9 4.23 144.1-147.6 93.3 
10 0.76 146.1-148.7 55.6 
11 0.45 liquid at r.t - 
12 0.47 liquid at r.t - 
13 1.0 liquid at r.t - 
14 0.33 liquid at r.t - 
15 - - - 
Melting points were recorded on a Stuart™ Digital Melting Point Apparatus and were 
uncorrected. 
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Table 6: Molecular Formula, Molecular Weight & Mass Spectral Data of the 
Synthesised Compounds 
Code 
Molecular 
Formula 
Molecular 
Weight (Mw) 
Mass (m/z) 
1 C13H10ClNO 231.67 
[M+] 231 (Abundance – 2400000).  
[M+2] 233 caused by 37Cl isotope. 
2 C18H16Cl2O4 367.22 
[M+] 367 (Abundance – 100000). 
[M+2] 369 caused by 37Cl isotope. 
Base peak is 335, shows the loss 
of a methoxy group. Other peaks 
seen: 366 (loss of H+). 
3 C16H12Cl2O4 307.17 
[M+] 307 (Abundance – 1200000). 
[M+2] 309 caused by 37Cl isotope. 
Base peak is 306 (loss of H+)   
4 C15H13Cl2O2 292.14 
Base peak is 149. 295 is closest 
fragment.  
5 C13H9ClO2 232.66 
[M+] 232 (Abundance – 26800). 
Base peak is 231 (loss of H+). [M+2] 
234 caused by 37Cl isotope.  
6 C15H12NClO 257.71 
No MS obtained as sample had run 
out before testing took place. 
7 C15H10BrFO 305.13 
[M+] 305 (Abundance – 190000). 
[M+2] 307 caused by 37Cl isotope. 
Base peak is 225 caused by the 
loss of a bromine atom. 
8 C15H10ClFO 260.68 
[M+] 260 (Abundance – 100000). 
[M+2] 262 caused by 37Cl isotope. 
Base peak is 75. 
9 C15H12NBrO 302.16 
[M+] 302 (Abundance – 76000). 
[M+2] 304 caused by Br isotope. 
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Base peak is 287/286 (loss of 
methyl group).  
10 C18H16Cl2O4 367.22 
366 is closest fragment with 368 
seen as the peak caused by 81Cl 
isotope. Base peak is 335, possibly 
caused by the loss of a chlorine 
atom.  
11 C15H10ClFS 276.75 
267 is closest fragment with 269 
seen as the peak caused by 37Cl 
isotope. Base peak is 207, also 
peak 209 caused by isotope.  
12 C16H12Cl2OS 323.23 
320 is closest fragment, [M+2] peak 
not seen. Base peak is 306, same 
m/z as starting reagent (3) 
13 C15H10BrFS 321.21 
Base peak is 75. 260 peak seen, 
same m/z as starting reagent (7) 
with 261 seen as [M+2] peak.  
14 C15H12NBrS 318.22 
318 was seen. Base peak is 303, 
same m/z as starting reagent (9). 
[M+2] 304 (starting material) and 
319 [M+1] seen.  
15 C26H31CN2O4 470.98 MS not obtained. 
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Table 7: Infra-Red Spectroscopy Data of Synthesised Compounds 
Code Absorption (cm-1) Appearance Group 
1 
3268 Medium N-H stretch 
1643 Medium C=C stretch 
817 Strong C-Cl stretch 
2 
1645 Medium C=C stretch 
840 Strong C-Cl stretch 
3 
1653 Medium C=C stretch 
823 Strong C-Cl stretch 
4 
1645 Medium C=C stretch 
1206 Strong C-O (OH) stretch 
819 Strong C-Cl stretch 
5 
2032 Weak C-H aromatic bend 
1653 Medium C=C stretch 
778 Strong C-Cl stretch 
6 - - - 
7 
2032 Weak C-H aromatic bend 
1699 Strong C=O conjugated ketone stretch 
668 Strong C-Br stretch 
8 
1662 Medium C=C stretch 
1005 Strong C-F stretch 
813 Strong C-Cl stretch 
9 
1618 Weak C-H aromatic bend 
1688 Strong C=O Conjugated ketone stretch 
573 Strong C-Br stretch 
10 
1650 Medium C=C stretch 
1445 Medium CH (methyl) bend 
821 Strong C-Cl stretch 
11 - - - 
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12 - - - 
13 - - - 
14 - - - 
15 - - - 
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Key: chemical shift (), peak splitting pattern, J coupling constant (Hz), integration 
s – singlet, d – doublet, dd – doublet of doublets, t – triplet, d of t – doublet of triplets, m – multiplet 
Table 8: 1H NMR Data of Synthesised Compounds 
 
Image 1 
 
Image 2 
^ - see image 1 for reference, • - see image 2 for reference 
*  - thiochalcone 
R = H unless otherwise stated 
Code Hα Hβ R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 
1^ X = 
NH, R6 = 
Cl 
7.33, d, 
16Hz,  
1H 
7.80, d, 
16Hz, 
1H 
7.39, m, 
1H 
6.28, m, 
1H 
7.17, m, 
1H 
7.59, d, 
8Hz, 1H 
7.41, d, 
8Hz, 1H 
- 
7.41, d, 
8Hz, 1H 
7.59, d, 
8Hz, 1H 
- - 
2• R2 = 
Cl, R3 = 
Cl, R6, 
R8, R10 
= OCH3 
6.53, d, 
14Hz, 1H 
6.88, d. 
14Hz, 1H 
7.69, s, 
1H 
- - 
7.70, d, 
8Hz, 1H 
7.86, d, 
8Hz, 1H 
3.93, s, 
3H 
6.16, s, 
1H 
3.89, s, 
3H 
6.16, s, 
1H 
3.93, s, 
3H 
3• R1 = 
Cl, R3 = 
Cl, R8 = 
OCH3 
7.00, d, 
16Hz, 1H 
7.44, d, 
16Hz, 1H 
- 
7.50, d, 
2Hz, 1H 
- 
7.37, dd, 
2Hz,8Hz, 
1H 
7.42, d, 
8Hz, 1H 
7.54, d, 
8Hz, 1H 
(overlap 
with R10) 
6.94, d, 
8Hz, 1H 
3.87, s 
6.94, d, 
8Hz, 1H 
7.54, d, 
8Hz, 1H 
(overlap 
with R6) 
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4• R1 = 
Cl, R3 = 
Cl, R8 = 
OH 
7.82, d, 
8Hz, 1H 
7.75, d, 
8Hz, 1H 
- 
8.36, d, 
2Hz, 1H 
- 
7.37, dd, 
2Hz, 8Hz, 
1H 
7.43, d, 
8Hz, 1H 
7.54, d, 
9Hz, 1H 
6.94, d, 
9Hz,1H 
- 
6.94, d, 
9Hz, 1H 
7.54, d, 
9Hz,1H 
5^ X = O, 
R6 = Cl 
7.36, d, 
16Hz, 1H 
7.68, d, 
16Hz, 1H 
7.84, d, 
16Hz, 1H 
6.63, m, 
1H 
7.45, d, 
4Hz, 1H 
7.60, d, 
8Hz, 2H 
7.41, d, 
9Hz, 2H 
- 
7.41, d, 
9Hz, 1H 
7.60, d, 
8Hz, 2H 
- - 
6• R3 = 
NH2, R8 = 
Cl 
7.75, d, 
16Hz, 1H 
7.81, d, 
16Hz, 1H 
- - 
NH2 at 
8.45, s, 
2H 
6.73, d, 
9Hz, 1H 
7.89, d, 
9Hz, 1H 
8.11, d, 
8Hz, 1H 
7.30, d, 
8Hz, 1H 
- 
7.30, d, 
8Hz,1H 
8.11, d, 
8Hz, 1H 
7• R3 = 
Br, R8 = 
F 
7.50, d, 
16Hz, 1H 
7.79, d, 
16Hz, 1H 
7.60, d, 
8Hz, 1H 
7.43, d, 
8Hz, 1H 
- 
7.43, d, 
8Hz, 1H 
7.60, d, 
8Hz, 1H 
8.08, dd, 
8Hz, 5Hz, 
1H 
7.21, t, 
8Hz, 1H 
- 
7.21, t, 
8Hz, 1H 
8.08, dd, 
8Hz, 5Hz, 
1H 
8• R3 = F, 
R8 = Cl 
7.42, d, 
16Hz, 1H  
7.81, d, 
16Hz, 1H 
7.67, dd, 
9Hz, 4Hz, 
1H 
7.15, t, 
9Hz, 1H 
- 
7.15, t, 
9Hz, 1H 
7.67, dd, 
9Hz, 4Hz, 
1H  
7.67, d, 
9Hz, 1H 
7.91, d, 
9Hz, 1H 
- 
7.91, d, 
9Hz, 21 
7.67, d, 
9Hz, 1H 
9•  - - - - - - - - - - - - 
10• R1 = 
Cl, R3 = 
Cl, R6, 
R8, R10 
= OCH3 
7.48, d, 
16Hz, 1H 
7.95, d, 
16Hz, 1H 
- 
7.47, d, 
2Hz, 1H 
- 
7.33, dd, 
8Hz, 2Hz, 
1H 
7.43, 
8Hz, 1H 
3.87, s, 
3H 
6.12, s, 
1H  
3.87, s, 
3H 
6.12, s, 
1H 
3.87, s, 
3H 
11* R3 = 
F, R8 = 
Cl 
- - - - - - -  - - - - - 
12* R2 = 
Cl, R3 = 
6.83, d, 
16Hz, 1H 
7.43, d, 
16Hz, 1H 
- - - 
7.31, d, 
8Hz, 1H 
7.00, d, 
8Hz, 1H 
 
7.36, dd, 
16Hz, 1H 
3.70, s, 
3H 
7.25, dd, 
8Hz, 1H 
- 
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Cl,  R8, = 
OCH3 
13* R3 = 
Br, R8 = 
F 
 
- - - - - - - - - - - - 
14* R3 = 
NH2, R8 = 
Br 
- - - - - - - - - - - - 
 
Peaks for compounds 9, 11, 13 and 14 were not assigned in this table. Compound 9’s spectra is explained further in table 13 and the discussion whilst compound 11, 13 
and 14’s spectra is explained in table 12 and the discussion. 
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Key: chemical shift (), peak splitting pattern, J coupling constant (Hz), integration 
s – singlet, d – doublet, dd – doublet of doublets, t – triplet, d of t – doublet of triplets, m – multiplet 
Table 9: 13C NMR Data of the Synthesised Compounds 
 
 
Image 1 
 
 
Image 2 
^ - see image 1 for reference, • - see image 2 for reference 
*  - thiochalcone 
Code C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 
1^ X = 
NH, R6 
= Cl 
129.2 111.1 116.4 136.3* 178.4 125.4 140.9 125.7 * 129.6 128.9 132.5* 128.9 129.6 - - 
2• R2 = 
Cl, R3 
= Cl, 
R6, R8, 
R10=O
CH3 
129.6 136.1* 136.3* 126.3 131.5 155.3* 196.5 126.7 131.5 106.3* 163.- 91.5 166.9 91.5 163.0 
3• R1 = 
Cl, R3 
= Cl, 
130.3* 123.7 130.1* 127.2 123.2 130.5* 187.6 131.5 146.3 141.0* 130.7 114.5 
OCH3 
at 55.4 
114.5 130.5 
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R8 = 
OCH3 
4• R1 = 
Cl, R3 = 
Cl, R8 = 
OH 
131.0 132.2* 136.1* 129.6 132.0 138.5* 187.2 128.9 146.8 126.1* 131.8 116.3 160.3 116.3 131.8 
5^ X = 
O, R6 
= Cl 
148.5 113.3 131.0 - 178.5 121.5 142.3 - 130.0 129.0 - 129.0 130.0 - - 
6• R3 = 
NH2, 
R8=Cl 
130.0 113.9 133.4* 113.9 130.0 134.2* 189.2 129.1 130.5 -135.6* 130.6 130.2 138.1* 130.2 130.6 
7• R3 = 
Br, R8 
= F 
129.6 129.4 131.1 129.4 129.6 133.5* 189.5 121.9 131.1 136.5* 130.1 116.1 134.1* 116.1 130.1 
8• R3 = 
F, R8 = 
Cl 
130.2 116.1 165.4 116.1 130.2 131.0* 189.6 121.3 144.1 136.5* 130.1 132.2 134.1* 132.2 130.1 
9• - - - - - - - - - - - - - - - 
10• R1 
= Cl, 
R3 = 
Cl, R6, 
R8,R10
=OCH3 
132.6* 129.9 133.1* 126.9 125.6 106.1* 194.4 130.4 138.3 136.3* 
 OCH3 
at 55.8 
90.5 
OCH3 
at 55.4 
90.5 
 OCH3 
at 55.8 
11* R3 
= F, R8 
= Cl 
- - - - - - - - - - - - - -  
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12* R2 
= Cl,R3 
=Cl,R6, 
R8,R10
=OCH3 
- 126.9 - 126.9 123.6 - 200.8    132.0 130.5 - 130.5 132.0 
13* R3 
= Br, 
R8 = F 
- - - - - - - - - - - - - - - 
14* R3 
= NH2, 
R8 = Br 
- - - - - - - - - - - - - - - 
 
Peaks for compounds 9, 11, 13 and 14 were not assigned in this table. Compound 9’s spectra is explained further in table 13 and the discussion whilst compound 11, 
13 and 14’s spectra is explained in table 12 and the discussion.  
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Table 10: 1H-1H COSY Correlations for Synthesised Compounds 
Code COSY Coupling 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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7 
 
8 
 
9 - 
10 
 
11 - 
12 
 
13 - 
14 - 
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Table 11: 1H-13C HMBC Correlations of Synthesised Compounds 
Code HMBC Coupling 
1 
 
2 
 
3 
 
4 
 
5 
 
6 - 
47 
 
7 
 
8 
 
9 - 
10 
 
11 - 
12 
 
13 - 
14 - 
 
Regarding the 1H and 13C NMR of compounds 11, 13 and 14, refer to the table 
below.  The spectra for compound 14 showed that the expected compound was not 
isolated. Instead, the oxa-thio-phosphorane compound, a breakdown product from 
the Lawesson’s Reagent mechanism was found to be the major product isolated 
after column chromatography.  
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Table 12: 1H, 13C and 1H-1H COSY NMR Data for oxa-thio-phosphorane using 
spectra of compound 14 
 
1H NMR Data 
Key: chemical shift (), peak splitting pattern, J coupling constant (Hz), 
integration 
C1 C2 C3 C4 C5 C6 
7.6, d, 
12Hz, 1H 
7.04, d, 
9Hz, 1H 
methoxy 
group: 3.8, 
s, 3H 
7.04, d, 
9Hz, 1H 
7.6, d, 
12Hz, 1H 
- 
13C NMR Data 
C1 C2 C3 C4 C5 C6 
132.9 113.9 163 113.9 132.9 123.8 
1H-1H COSY Data 
 
1H-13C HMBC Data 
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Whilst analysing the data for compound 9 and consolidating the synthetic workup 
of this compound, it is clear that its structure is not a chalcone but the structure 
below. For further explanation, see discussion (4.2).  
Table 13: 1H, 13C and 1H-1H COSY NMR Data for compound 9 
 
 
R = H 
1H NMR Data 
Key: chemical shift (), peak splitting pattern, J coupling constant (Hz), 
integration 
R1 R3 R4 R6 R8 R9 R10 R12 R13 
8.03, d, 
8Hz, 
1H 
8.03, 
d, 
8Hz, 
1H 
7.80, 
d, 
8Hz, 
1H 
7.80, d, 
8Hz, 
1H 
8.41,s 
1H 
7.65, 
d, 
8Hz, 
1H 
7.24, 
d, 
7Hz, 
1H 
7.24, 
d, 
7Hz, 
1H 
7.65, d, 
8Hz, 
1H 
Methyl group of acetophenone: 2.64, s 
13C NMR Data 
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C1 C2 C3 C4 C5 C6 C7 C8 C9 
129.9 132.4 129.9 121.0 - 121.0 156.1 134.7 130.1 
C10 C11 C12 C13 Methyl group of acetophenone: 26.4, 
carbonyl group – 191.1 131.9 126.6 131.9 130.1 
1H-1H COSY NMR Data 
 
 
1H-13C HMBC 
 
 
 
 
 
Compound 15 proved difficult to isolate clean with column chromatography. The 
peak assignments have been done with extensive use of 1H, 13C and 1H-1H COSY 
spectra. 
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Table 14: 1H, 13C and 1H-1H COSY NMR Data for Compound 15 
1H NMR Data 
 
R = H 
R1 R2 R4 R5 R6 R7 R8 R9 R11 R12 H* 
7.40, 
d, 
8Hz, 
1H 
7.60, 
d, 
9Hz, 
1H 
7.60
, d, 
9Hz, 
1H 
7.40, 
d, 
8Hz, 
1H 
7.33, 
d, 
8Hz, 
1H 
7.88
, d, 
8Hz, 
1H 
7.72
, d, 
8Hz, 
1H 
7.99
, d, 
7Hz, 
1H 
7.99
, d, 
7Hz, 
1H 
7.72
, d, 
8Hz, 
1H 
3.89
, m, 
1H 
Methyl groups of amino acid – 0.81, 2 x d, 12Hz 
13C NMR Data 
 
 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 
130.9 119.05 - 
119.0
5 
130.
9 
- - - - - - 
C13 C14 C15 Carbonyl of amino acid – 175.3, methyl groups of amino 
acid – 28.5, CH* – 52.4  - - - 
A majority of the peaks were not assigned as the resolution of the spectra did 
not allow for the peaks to be seen. An increased number of scans whilst 
recording the spectra would have alleviated the issue.  Also, the Boc protecting 
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group appears to have been removed as its methyl peaks are missing on both 
1H and 13C data. 
1H-1H COSY NMR Data 
 
1H-13C HMBC 
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Table 15: In-vitro Antimicrobial Activity of the Synthesised Compounds 
Code 
Zone of Inhibition (mm)* 
Concentration 
(mg/ml) 
Bacteria  
S. epidermidis P. aeruginosa E. coli 
1 10 - - - 
2 10 - - - 
3 10 - - - 
4 10 - - - 
5 10 - - - 
6 10 - - - 
7 10 - - - 
8 10 - - - 
9 10 - - - 
10 10 - - - 
11 10 10 - - 
12 10 - - - 
13 10 - - - 
14 10 16 10.3  0.334 11.3  0.334 
Ciprofloxacin 10µg 15.3  0.334 18 15.3  0.334 
* mean value given (n=3) 
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Table 16: Minimum Inhibitory Concentration (MIC) of the biologically active 
compounds 
Code 
MIC (mg/ml) 
S. epidermidis P. aeruginosa E. coli  
11 1.25 - - 
14 0.3125 1.25 1.25 
Ciprofloxacin* 1 0.5 0.25-0.5 
*(mg/L), as reported by EUCAST 
(n=3) 
 
Table 17: Minimum Bactericidal Concentration (MBC) of the biologically active 
compounds 
Code 
MBC (mg/ml) 
S. epidermidis P. aeruginosa E. coli  
11 2.5 - - 
14 1.25 2.5 2.5 
(n=3) 
 
Discrepancies between the MICs and MBCs are further discussed in the discussion 
(4.4). The activity of the synthesised compounds was adequately recorded and 
noted.  
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4. Discussion 
4.1 Data Analysis 
This project is made up of two key aspects: the synthesis of chalcones and 
thiochalcones followed by the determination of their activity as antimicrobial agents. 
In order to prove the existence of the compounds synthesised, the data procured 
from their analytical examination had to be studied.  
As seen in tables 8, 9, 10 and 11, each synthesised compound has had their 1H and 
13C NMR analysed. The spectra derived from these analytical experiments including 
1H-1H Correlation Spectroscopy (COSY) and 1H-13C Heteronuclear Multiple Bond 
Correlation Spectroscopy (HMBC) can be found in the appendix. Diagnostically, the 
most important protons to be identified in a chalcone are the protons on the α-β 
unsaturated bond as these only arise from a successful Claisen-Schmidt 
condensation and complete conjugation of the electron system. 
The synthesised compounds have several substituents, causing the magnetic 
equivalency of the protons to change. Compounds 1 and 5 had 5-membered A rings. 
Compound 1 showed coupling of its α-β unsaturated protons at 7.33 and 7.80 with 
J coupling constants of 16Hz as did compound 5 with coupling seen at 7.41 and 
7.69 with J coupling constants of 16Hz. Compounds 2, 3, 4 and 10 have dichloro 
substituents on the A ring with their α-β unsaturated protons around 6.53-7.95 with 
coupling constants around 14-16.8Hz, with the exception of compound 4, whose α-
β unsaturated protons have a coupling constant of 16 Hz. Compounds 2 and 10 
have trimethoxy substituents on the B ring. The remaining compounds had either a 
halogen (Cl or Br), methoxy or hydroxyl group in the 4th position on the B ring. Peaks 
were typically seen in the 7-8 region which is where aromatic protons usually occur 
(see appendix 1.1.1 for 1H NMR spectra of compound 1, 1.2.1 for compound 2 and 
so on). Infra-red spectroscopy showed weak peaks at 1645 cm-1 across all the 
derived spectra, correlating to the C=C bond stretch in the aromatic ring. The C-F 
and C-Cl stretch around 800 cm-1 and 1000 cm-1 were seen across all halogenated 
compounds such as 1, 2, 3, 4, 5, 8, 9 and 10.  
Compound 9’s synthesis did not require the addition of sodium hydroxide to induce 
a colour change or precipitation. The amino group on the 4-aminoacetophenone 
bears a lone pair of electrons on the nitrogen. This could have facilitated the 
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nucleophilic addition of the benzaldehyde with the acetophenone in solution 
(scheme 5).  
 
 
 
 
The TLC of the compound showed one spot (solvent system: hexane & DCM, 1:1). 
The 1H spectrum supports the proposed structure. The aromatic protons formed 
doublets at 8.03, 7.80, 7.65 and 7.24 respectively whilst the benzylidene proton 
can be seen as a singlet at 8.41. The GCMS data of the compound produced a 
pair of M+ peaks at m/z 303/305 indicative of bromine being present in the molecule. 
HMBC correlations were used to assign the aromatic doublets as belonging to ring 
A or ring B.  
Scheme 5: Mechanism of Reaction between 4-
aminoacetophenone & 4-bromobenzaldehyde 
Image source: author’s own 
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Also, the NOESY spectra for compound 9 does not show a correlation between the 
protons with asterisks (see figure 17) suggesting the compound is of this shape.  
 
 
 
The use of Lawesson's Reagent to convert the carbonyl to a thiol in this particular 
compound would have been possible (see scheme 6). However, the spectra for the 
attempted conversion, compound 14, was consistent with the oxa-thio-phosphorane 
compound which is further discussed in the next section. 
Upon analysing Nuclear Overhauser Effect Spectroscopy (NOESY) data, a cross 
peak correlating the α-β unsaturated proton was seen across a majority of the 
spectra (see appendix 1.1.6 for compound 1 spectrum), which suggests the cis (Z) 
isomer of the chalcones was synthesised. However, the high J coupling constants 
of these protons, typically seen at 16Hz in this project, (see table 7) indicate the 
conformation of the chalcones to be trans (E) isomers as well as geometrically pure 
(Tran et al, 2012). These are the thermodynamically most stable form (Aksöz et al, 
2011). 
In any chemical reaction in which two isomers can be formed, there is always a 
kinetic product and a thermodynamic product. The kinetic product is usually formed 
when the reaction time is short, not giving the thermodynamic product time to form. 
The use of a strong base minimises the chances of reversibility at the intermediate 
step, enhancing the formation of the thermodynamic product – the trans (E) isomer 
(see scheme 2).  
 
A possible explanation for the appearance of this cross peak was the interaction of 
a chalcone molecule with another molecule by way of pi stacking. Seeing as NOESY 
data aims to show signals that arise from protons that are of close proximity in 
space, this theory fits. The formation of aggregates in solutions is a naturally 
Figure 17: Shape of Compound 9 
Image source: author’s own 
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occurring phenomena that occurs with supramolecules (Perez et al, 2013). It is likely 
that a trans (E) isomer was in close contact with a neighbouring trans (E) isomer 
aggregate, resulting in a strong signal on the NOESY data. The high coupling 
constants of the α-β protons still suggest that the trans (E) isomer is the abundant 
product. So, it became imperative to understand why this peak was being shown.  
 
It was hypothesised that the use of an aprotic solvent as well as a dilute sample for 
NMR would reduce the formation of aggregates and this would result in the loss of 
the cross peaks in the NOESY spectrum. The 1H NMR data of aggregates are 
different from those of monomeric species depending on the concentration and 
temperature that the data is acquired (Perez et al, 2013).  
 
A suggestion was made to acquire new NOESY data and diffusion-ordered 
spectroscopy (DOSY) NMR data to make a comparison. DOSY separates the NMR 
signals of different compounds according to their diffusion coefficient. Ideally, 
signals arising from the same compound should appear in one consecutive row. By 
acquiring NOESY data from both a concentrated and dilute sample, this was meant 
to show the cross peak caused by pi stacking of trans (E) isomers due to the 
concentrated sample and its disappearance with a dilute sample. In terms of DOSY 
data, two rows of peaks were expected from the concentrated sample – one caused 
by the pi stacked aggregate and the by the free trans (E) isomer. In the dilute 
sample, only a row caused by the trans (E) isomer was expected.  
 
Compound 10 was used to acquire this new data. The new DOSY data from both 
its concentrated and dilute sample showed the expected set of peaks.  
 
 
59 
 
 
 
 
 
 
The concentrated sample showed two rows of signals. The first row showed two 
peaks, most likely corresponding with the α-β unsaturated protons of the pi 
stacked aggregates of the trans (E) isomer. The second row showed a number of 
peaks, corresponding with the free trans (E) isomer.  
 
The dilute sample of 10 showed a single row of peaks caused by the trans (E) 
isomer.  
 
Figure 18: DOSY spectrum of Compound 10 
(concentrated in DMSO) 
Image source: author’s own 
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Also, as a standard experiment, new 1H proton data was derived. There was a 
considerable difference between the original (concentrated) data derived in 
chloroform compared to the new (dilute) data derived in DMSO. The peaks of the 
dilute sample had shifted down the ppm scale, giving the peaks new chemical shift 
values (see appendix 1.1.18). The shift was considerably large, too large to be 
caused solely by solvent alterations. This was thought to support the hypothesis that 
the aromatic stacking of the trans (E) aggregates and free trans (E) conformations 
was at play.  
 
However, the large coupling constants of the α-β unsaturated protons highly suggest 
the presence of the exclusively trans (E) isomer. Further reading suggested that the 
cross peaks seen on the NOESY spectra could be caused by the strong COSY 
correlation between the protons, resulting in the false NOESY peak (Claridge, 
2009). In a third attempt to confirm whether this cross peak was a result of pi 
stacking or a strong COSY correlation, new NOESY and DOSY data was obtained 
(concentrated and dilute samples in both deuterated chloroform and DMSO) and it 
was clear that the cross peak was false. The new data was obtained in both 
chloroform and DMSO to negate the differing effects across the solvents. It was also 
taken at 600MHz for increased sensitivity. From the DOSY data (see figures 20 and 
Figure 19: DOSY spectrum of Compound 10 (dilute 
in DMSO) 
Image source: author’s own 
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21), it is clear that a single compound is present under both the concentrated and 
the dilute sample conditions. 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: DOSY spectrum of Compound 10 
(dilute in chloroform) – 600MHz 
Image source: author’s own 
 
Figure 21: DOSY spectrum of Compound 10 
(dilute in DMSO) – 600MHz 
Image source: author’s own 
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In a former project, previous attempts to synthesise chalcones using the Claisen-
Schmidt condensation method using similar reagents produced a two-step 
synthesis: the reaction of the benzaldehyde and acetophenone to give an aldol 
which was further dehydrated to form the required chalcone. It was suggested that 
using a stronger base such as potassium or lithium hydroxide to catalyse the 
benzaldehyde and acetophenone reaction would have avoided the synthesis of the 
aldol. During this project, sodium hydroxide was the base used and it was not 
changed as it facilitated the reactions without forming an aldol; it was not detected 
during analysis. The expected colour changes (clear-yellow) were seen in all the 
chalcone reactions. If this was not seen after the addition of the sodium hydroxide 
solution, this would have given a reason to either make use of a stronger base or 
allow for longer reaction times.  
 
A typical Claisen-Schmidt condensation is carried out at room temperature but the 
reactions in this project were carried out at 50-65°C, maximising the chance for the 
thermodynamic product to be made in situ. The synthesis of exclusively cis-
chalcones is underreported in literature but they are also the thermodynamically less 
stable isomer and so tend to decompose before their presence can be denoted 
(Zhuang et al, 2017). There has been a report of isomerisation of the trans (E) 
chalcone to the cis (Z) chalcone by exposing the methanolic solution of the chalcone 
to visible white light (Iwata et al, 1997). The chances of this photo-isomerisation 
occurring to the synthesised chalcones was small as they were kept in a dark place 
until required.  
 
4.2 Thiochalcones 
A mechanism of the conversion of chalcones to thiochalcones is as follows: 
Lawesson’s reagent in solution exists in equilibrium as two molecules of 
dithiophosphine ylide. A single molecule of the ylide attacks the carbon of the 
chalcone’s carbonyl bond (C=O) via the P=S bond, producing a thiaoxaphosphetane 
intermediate. This intermediate undergoes an intramolecular attack forming the P-
O bond, which is the driving force of this reaction (similar to the Witting Reaction). 
This produces the thiochalcone and two molecules of oxa-thio-phosphorane. 
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As stated in the literature review (1.1.3), the thionation reaction can produce a 
mixture of products. Krstić et al utilised Lawessons’s Reagent to convert α-β 
unsaturated steroidal ketones to their thio- equivalents. They noticed that the type 
of products and their ratio was dependant on reaction conditions. When using 
anhydrous toluene for 8 hours at refluxing temperature, the reaction produced a 
mixture of the steroidal ketones’ corresponding dimer-sulfides and the starting 
Scheme 6: Mechanism for Conversion of Chalcones to Thiochalcones 
Using Lawesson’s Reagent 
Image source: author’s own 
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ketone. The desired product was not seen after the 8-hour reaction but was isolated 
when the reaction time was 25-45 minutes (Krstić et al, 2010). Even though reaction 
times did not reach 8 hours (excluding compound 14 that had a reaction time of 12 
hours), they did exceed 25-45 minutes, so it is assumed this was the case with 
compounds 11, 13 and 14. Upon analysing their analytical data, it is clear that the 
eliminated oxa-thio-phosphorane is the abundant product (see table 10). Compound 
12 is the exception as a mixture of the thiochalcone, starting chalcone and oxa-thio-
phosphorane compound is present upon analysis of 1H, 13C and 31P NMR data (see 
tables 7, 8 and 9).  
 
 
 
The 1H and 13C NMR of 11, 13 and 14 (see appendices 1.11, 1.12 and 1.13) 
resembles that of the predicted NMR of the oxa-thio-phosphorane compound (see 
appendices 1.1.16 and 1.1.17). The spectra share the following factors in common: 
the presence of a doublet of doublets at both 7.6 - 7.8 and 7 - 6.7 as well as a 
singlet at 3.8 corresponding with the methoxy group on the ring. The protons are 
also coupled on their respective 1H-1H COSY spectra. The C=S bond that should 
appear around 200ppm, is missing on the 13C NMR of all the compounds as well as 
the C=O bond that should appear around 180ppm, but a number of aromatic 
carbons appear in the region of 110-130ppm. The α-β unsaturated carbon peaks, 
that should appear around 130ppm and 110ppm respectively, are also not seen on 
13C data. It should also be noted that a peak seen at 193.2ppm on the 13C of 12 
could correspond with the C=O bond whilst a peak at 200.8ppm could be the C=S 
peak (see appendix 1.12.7). No I.R data was obtained as it was clear from the NMR 
data that the expected products were not formed. 
The GCMS data of some of the thionated compounds shows that their most 
abundant peak corresponds to the M+ peak of their corresponding starting 
chalcones (see table 6). Compound 12’s M+ peak is the same M+ peak as its 
starting chalcone, compound 3 (m/z – 306) as is the case with compound 14’s M+ 
peak and compound 9 (m/z – 303). This evidence suggests that the thiochalcones 
Figure 22: oxa-thio-phosphorane  
Image source: author’s own 
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were made but possibly decomposed, as its monomeric species is unstable (Krstić 
et al, 2010).  
Another method of ascertaining the presence of thionated products is a colour 
change. A purple colour is associated with the presence of a thionated product and 
this was reflected in the synthesis of compound 14, which retained this colour after 
the completion of the reaction whilst the remaining compounds had a colour change 
of bright orange to yellow. Compound 11 maintained a bright orange colour.   
15P NMR was conducted to ascertain the presence of phosphorous in all the 
thiochalcone samples. The peaks seen on their respective spectra (see appendix 
1.11.8 for 15P spectrum of compound 11) also support the presence of oxa-thio-
phosphorane.  
4.3 Effect of Substituents Positions on Aromatic Rings on the Reaction 
Aldehydes bearing electron-withdrawing groups favour base-catalysed 
condensations whilst aldehydes bearing electron-donating groups favour acid-
catalysed condensations (Zhuang et al, 2017). The below average yields of the 
compounds could be explained by this fact. 2, 4, 6-trimethoxybenzaldehyde was 
used to synthesise compounds 2, 3 and 10. The methoxy group is electron-
donating. The use of sodium hydroxide to catalyse its reaction suggests the 
aldehyde combining with the acetophenone was the rate-determining step of this 
reaction, resulting in the average yields of 52.37%, 30.72% and 55.65% 
respectively.  
Halogen groups are strongly electronegative and withdraw electron density from the 
ring via induction. They are ortho/para-directors when it comes to electrophilic 
substitution, due to the ability of the lone pairs to stabilise the carbocation formed 
during the substitution process when in the ortho and para positions.  The overriding 
effect on the aromatic ring in the chalcones studied here, would be one of electron-
withdrawing induction as we are not looking at electrophilic substitution (see figure 
23). 
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4-chlorobenzaldehyde, 4-fluorobenzaldhyde and 4-bromobenzaldehyde were used 
in the synthesis of compounds 1, 5, 6, 7, 8 and 9 that produced yields of 100.7%, 
40.28%, 51.97%, 64.92%, 89.51% and 93.32% respectively. These compounds 
produced a mixture of good and average yields. 
The electron-withdrawing effects of the halogens in the para position means the 
reactions would have produced good yields under basic conditions. The below-
average yields of compound 6 could be due to an inadequate reaction time whilst 
the higher yields of compounds 1 and 9 could mean the products were a mixture of 
starting material and desired product.  
Compound 4 was synthesised using sodium hydroxide, but the precipitate did not 
form until the use of concentrated sulphuric acid followed by a liquid-liquid 
extraction. Its uncharacteristically high yield of 138% is most likely due to the 
presence of water. Further drying would be needed for an accurate yield.    
4.4 Antimicrobial Activity  
Out of all the synthesised products, only two supposed thiochalcones displayed any 
antimicrobial activity. The remaining compounds, chalcones especially, did not 
display any activity. The reasons for this could be due to a number of factors but it 
is most likely the substituents on the A and B rings.  
A free hydroxyl group on the B ring of a chalcone is necessary for biological activity, 
regardless of the substituents on the A ring (Ávila et al, 2008). Compound 4 bears 
a free hydroxyl group on the B ring, but no antimicrobial activity was noticed when 
the compound was tested. A hydroxyl group in the meta position has been noted to 
bring about a diminished level of antimicrobial activity previously (Silva et al, 2013) 
but compound 4’s hydroxyl group was in the para position.  
Figure 23: Non-hydrogen positioning on aromatic ring 
relative to ketone moiety 
Image source: author’s own 
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More than 2 methoxy groups on the B ring have been seen to eradicate any 
biological activity of a chalcone regardless of the substituents on the A ring (Baba 
et al, 2013) as is reflected in the results of compounds 2 and 10, which are structural 
isomers. Compound 3 has a methoxy group in the para position. Such a group in 
the meta position proved useful in the Ávila et al study but the success of their 
compounds was attributed to hydrophobic groups such as prenyl or geranyl groups 
on the A ring (Ávila et al, 2008).  
 
The lack of activity from the synthesised halogen-bearing chalcones was 
unexpected. Halogens such as chlorine, bromine and fluorine are universally known 
to increase the biological activity of chalcones. The most prominent presumption to 
explain this feat is the negation of the halogens, present on both the A and B rings 
of the chalcone. Chalcones with halogens present on only one ring of the structure 
are seen to be antimicrobially active, as documented in studies conducted by Osório 
et al (2010), Burmaoglu et al (2017) and Karthikeyan et al (2007). 
 
Fundamentally, there are two pathways by which antibiotics can enter a bacterial 
cell: via a lipid-mediated pathway for hydrophobic antibiotics or through diffusion 
porins for hydrophilic antibiotics (Delcour, 2009).  
Bacterial membranes have a high phospholipid content which is negatively charged 
(Osório et al, 2010). Lipophilicity is an important factor of antimicrobial agents as 
they have to infiltrate the cell wall envelope of bacteria. Chlorine and bromine are 
rather lipophilic, but their electronegativity does not differ much compared to carbon. 
However, fluorine is more hydrophilic than other halogens so the presence of 
fluorine on the aromatic rings could have caused this lack of activity.  
There is a difference between the MIC and MBC values of compound 11 and 14. 
The compounds were very brightly coloured in nature, causing the determination of 
inhibition or otherwise difficult to distinguish. The determination of MBC requires the 
MIC results. When recording the MBC, the section with the smallest amount of 
growth prior to the section with zero growth was used to confirm the MIC. For 
instance, with compound 11, the MBC was recorded as 2.5 mg/ml but there was 
turbidity across all the wells during the MIC experiment. The section of the petri dish 
prior to 2.5 mg/ml had a very small amount of growth, meaning this correlates with 
the MIC of compound 11.  
 
68 
 
Existing antibiotics are split into classes: Beta-Lactams, Sulfonamides, 
Aminoglycosides, Tetracyclines, Chloramphenicol, Macrolides, Glycopeptides, 
Oxazolidinones, Ansamycins, Quinolones, Streptogramins and Lipopepties. The 
groups classify available antibiotics based on their target bacteria (Gram-negative 
or Gram-positive), mode of action (bactericidal or bacteriostatic) and chemical 
structure (Brunning, 2014).  
 
Antibiotics have five basic mechanisms of action against bacteria (Rollins and 
Joseph, 2000): 
 
1. Inhibition of cell wall synthesis 
2. Inhibition of protein synthesis 
3. Alteration of cell membranes 
4. Inhibition of nucleic acid synthesis 
5. Antimetabolite activity  
 
Peptidoglycan, a component of the cell walls of both Gram-positive and Gram-
negative bacteria, is made up of long, cross-linked polymers of B-N-acetyl-D-
glucosamine and N-acetylmuramic acid (Volmer et al, 2008). 
It is the D-alanyl-D-alanine portion of a peptide chain that is cross-linked in the 
presence of penicillin binding proteins (PBP). Beta-lactam and glycopeptide 
antibiotics target PBPs. Beta-lactam rings are thought to mimic the D-alanyl-D-
alanine portion of the peptide chain. They bind strongly with PBPs, thus weakening 
the peptidoglycan layer, resulting in the lysis of the bacterial cell (Tipper, 1985). 
Glycopeptides bind to the D-alanyl-D-alanine portion of the peptide chain, which 
disallows PBPs from binding, leading to the inhibition of cell wall synthesis 
(Nagarajan, 1991).  
Protein synthesis requires the action of DNA being used to synthesise mRNA via 
transcription. The bacterial 70S ribosome, a macromolecule required to translate 
mRNA to amino acids is made up of two subunits: 30S and 50S subunits. 
Aminoglycosides, chloramphenicol, tetracycline, oxazolidinones and macrolides 
work by affecting the process of translation by inhibiting certain parts of the 
ribosomal subunits. The inhibition of protein synthesis leads to a disruption of a 
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number of bacterial processes required for life, resulting in the death of the bacterial 
cell (Sigma-Aldrich, 2006). 
Quinolones inhibit the bacterial enzyme (deoxyribose nucleic acid) DNA gyrase, 
which is responsible for the ATP-dependent negative super-coiling of double-
stranded DNA. This is necessary to prevent the excessive positive supercoiling of 
the DNA strands when they separate for the commencement of replication or 
transcription. DNA gyrase is also made up of subunits, two A subunits and two B 
subunits. Quinlonines bind to the A subunits, disallowing the cutting and resealing 
of the DNA strands (Aldred et al, 2014).  
In terms of antimetabolite activity, sulfonamides, the “cousin” of the synthesised 
thiochalcones, inhibit bacterial folic acid production. They inhibit dihydropteroate 
synthase competitively, thus blocking the enzyme’s regular substrate, p-
aminobenzoic acid from binding. This prevents the production of folic acid in the 
bacterial cell. All living cells require folic acid for growth but it cannot cross bacterial 
cell walls via diffusion, so it is synthesised from p-aminobenzoic acid within the 
bacterial cell (Walzer et al, 1988).  
The varying antibiotic mechanisms of action shed light on the importance of 
enzymes in their activity. No concrete link has been made to define how chalcones 
work as antimicrobial agents. More studies would need to be carried out to 
determine the mode of action of chalcones and ascertain whether enzymes are 
involved in this process.  
At present, there are two theories that describe how enzymes bind to substrates: 
Lock and Key Theory and Induced Fit Theory. The conventional Lock and Key 
theory was introduced by Emil Fisher in 1894, postulating that a substrate was a key 
and the enzyme was the lock and that only the correctly shaped substrate would fit 
into the active site of the enzyme, thus activating it (Ophardt, 2003). The Induced 
Fit theory was suggested by Daniel Koshland in 1958 as experimental evidence of 
enzymatic activity could not be fully explained by the Lock and Key theory. Koshland 
suggested that it was the substrate that determined the final shape of the enzyme, 
meaning an enzyme’s active site is flexible in nature (Koshland, 1958). This means, 
a substrate would need to be recognisable to the active site in terms of functional 
groups, side chains or structure. This partially explains how enzymes can bind to 
competitive molecules that permanently block its active site.  
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A hypothesis developed in this study is that chalcones may follow a similar mode of 
action to generate antimicrobial activity. Chalcones could irreversibly block the 
active site of some bacterial enzymes, thus preventing its necessary action from 
being carried out, causing either bactericidal or bacteriostatic consequences.  
Sivakumar et al synthesised a series of substituted chalcones and tested their 
activity against S. aureus and E. coli. The study found that the active compound, 
with a methoxy group in the para position on the A ring and a hydroxyl group in the 
ortho position on the B ring, damaged the cell walls of the bacteria, reminiscent of 
the mechanism of action of glycopeptide antibiotics (Sivakumar et al, 2009). This 
mechanism involves blocking the active site of the enzyme D-alanyl-D-alanine 
carboxypeptidase/transpeptidase (Goodsell, 2002). This provides evidence that the 
mode of action chalcones undertake to behave as antimicrobial agents could 
possibly involve enzymatic inhibition.  
Relating back to the lipophilicity of the compounds, compounds 11 and 14 were the 
only biologically active compounds. To an extent, their activity could be caused by 
the presence of oxa-thio-phosphorane (see figure 22). If the activity shown was 
entirely due to this compound, activity would have been seen in compounds 12 and 
13 as well. Compound 11 does bear a fluorine atom on its B ring but it showed 
activity against the Gram-positive S. epidermidis. Gram-positive bacteria have a 
large peptidoglycan content in their cell wall (see figure 25). It may have been easier 
for this compound to cross the cell wall of S. epidermidis, supposedly boosted by 
the lipophilic sulphur atom on the thione moiety. With compound 14, it showed 
activity against both Gram-positive and Gram-negative bacteria: S. epidermidis, P. 
aeruginosa and E. coli. The compound contains nitrogen, sulphur and bromine. 
Nitrogen is lipophobic whilst sulphur and bromine are more lipophilic. The presence 
of these atoms in the compound may be the reason for the compound’s dual activity, 
allowing for passage across both cell walls, via a lipid-mediated pathway and 
through porins (Delcour, 2009), increasing the likelihood of the compound infiltrating 
the bacteria.  
The solubility of chalcones proved problematic during the bacterial screening of this 
project. An ideal solvent to work with in microbiology is either water or a 
physiological diluent as this would eliminate the possible effect of solvent interaction 
on any seen antimicrobial activity. DMSO was used as a compromise: it was the 
least bacterially disruptive solvent that the chalcones were soluble in. It was noticed 
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that when the chalcone solutions were introduced to the inoculated agar plates, 
there was a degree of precipitation of the chalcones. The most likely cause for this 
is the presence of water in the agar. Water is used during chalcone synthesis to 
initiate its precipitation. Antimicrobial susceptibility is usually tested using broth 
dilution, disk diffusion or gradient method (Reller et al, 2009). All these methods still 
utilise either agar or broth which requires water for its preparation. This antagonism 
between the chalcones and agar could have affected any activity or lack thereof. 
The synthesis of compound 15 was attempted in a bid to increase the solubility of 
chalcones in water, in turn, improving its bioavailability. Peptide couplings are 
usually facilitated by coupling reagents such as DCC and 4-Dimethylaminopyridine 
(DMAP). This synthesis made use of DCC and HOBt. DCC activates the carboxyl 
group of the amino acid by forming an O-acylisourea intermediate that forms a 
complex with HOBt. This complex couples with the amino end of compound 6, 
forming the desired product, the reformed catalyst HOBt and the by-product 
dicyclohexylurea (scheme 7). The reaction is usually carried out at low 
temperatures, facilitated by a mixture of dry ice and ether, to minimise the formation 
of this by-product. Freezing it overnight prompts its precipitation which can be 
filtered off before the work-up stage of the reaction. The strong smell of urea was 
used as an indicator of its presence throughout the reaction.  
It appears the Boc protecting group had been removed during the synthesis of 
compound 15 as the expected peak around 3.5 on the 1H spectra correlating with 
the group’s methyl substituents is missing. Usually, this removal is facilitated by the 
use of a strong acid such as trifluoroacetic acid. The workup section of the synthesis 
utilised 4% hydrochloric acid which would seem too weak to remove the protecting 
group but there was no other acid use in the synthesis. 
Compound 6 was chosen because of the presence of chlorine, with hopes of this 
compound being soluble in water but also antimicrobially potent due to the halogen. 
The 1H NMR of 15 (see table 11) showed that there was a mixture of starting 
chalcone (see appendix 1.15) and compound 15. However, starting reagent is 
evident on the 1H spectrum of 6 (see appendix 1.6) so this error was carried forward.  
It was difficult to clean compound 15 during column chromatography. Using a silica 
column still produced a very sticky compound. Its complete synthesis became 
secondary in a bid to continue synthesising chalcones with an increased premise of 
biological activity. 
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Scheme 7: DCC/HOBt amino acid-chalcone coupling 
mechanism 
Image source: author’s own 
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5. Conclusion 
The aim of this project was to synthesise a series of chalcones from a variety of 
substituted benzaldehydes and acetophenones. The prospect of a biologically 
active chalcone with a carbon-sulphur bond prompted the use of Lawesson’s 
Reagent in a bid to convert these chalcones to their thio-equivalents. To an extent, 
this was achieved upon analysis of the obtained NMR and GCMS data. The 
conformation of the synthesised chalcones has been confirmed as trans (E) from 
derived NOESY and DOSY data. 
The lack of activity from the synthesised chalcones could be caused by a multitude 
of reasons including the substituents made to their structures and the methodology 
selected to test their activity.  
The activity seen by thiochalcones 11 against S. epidermidis and 14 against E.coli, 
P. aeruginosa and S. epidermidis could be attributed to the eliminated oxa-thio-
phosphorane molecule, an inevitable by-product of the use of Lawesson’s Reagent. 
Compound 12, shown to have a higher ratio of the desired product did not show any 
activity against the bacteria used. However, the compounds could still be biologically 
active but towards other organisms such as viruses, protozoa and fungi (Zhuang et 
al, 2017).   
It has been repeatedly reported that modifications made to the chalcone structure 
enhances its biological activity. The chalcones synthesised during this study bore a 
variety of substituents including methoxy, hydroxyl and halogenic groups. The 
positioning of these groups has been linked to the biological activity and lack thereof 
in chalcones, as is reflected by the results of this study.  
The data from this project could contribute to the ever-expanding field of chalcone 
synthesis and their biological activity. It could also add to what is known of their 
structure-activity relationships, especially the importance of substituents and their 
positioning on the aromatic rings.  
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6. Future Works 
A bid to separate and isolate the products within compounds 11-14 could be 
undertaken to better understand the dynamics of a Lawesson’s Reagent-mediated 
thionation and to further understand what was displaying antimicrobial activity during 
this project. To expand on the biological activity of the synthesised chalcones, their 
cytotoxicity could be determined by running bio-assays on mammalian cells both 
normal and cancerous, possibly to reveal any anti-tumour behaviour.   
Reports of synergy between chalcones and antibiotics have been made (Belofsky 
et al, 2004). The possibility of this could be determined using the synthesised 
compounds, testing their efficacy with a variety of antibiotics and seeing whether it 
is worth further investigating in the use of chalcones in medicine as synergistic 
agents.  
Also, to understand the exact mode of action chalcones use to act as antimicrobial 
agents, a modelling/docking study in the active sites of key enzymes could be 
carried out. This would indicate whether enzymatic interaction is a possible cause 
for a chalcone’s antimicrobial activity. 
The purification of compound 15 should be undertaken. Solubility tests should also 
be conducted to ascertain whether the addition of an amino acid improves the 
solubility of a chalcone and whether it has an effect on its antimicrobial activity, if it 
displays any.  
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